Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

Delphine Saragoussi,1 Michael Cronquist Christensen,2 Lene Hammer-Helmich,3 Benoît Rive,4 Maëlys Touya,5 Josep Maria Haro6 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Medical Affairs Vortioxetine, H. Lundbeck A/S, Valby, Denmark; 3Real-World...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/b350346aca85438eb85845a04360f92e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b350346aca85438eb85845a04360f92e
record_format dspace
spelling oai:doaj.org-article:b350346aca85438eb85845a04360f92e2021-12-02T00:50:25ZLong-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study1178-2021https://doaj.org/article/b350346aca85438eb85845a04360f92e2018-05-01T00:00:00Zhttps://www.dovepress.com/long-term-follow-up-on-health-related-quality-of-life-in-major-depress-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Delphine Saragoussi,1 Michael Cronquist Christensen,2 Lene Hammer-Helmich,3 Benoît Rive,4 Maëlys Touya,5 Josep Maria Haro6 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Medical Affairs Vortioxetine, H. Lundbeck A/S, Valby, Denmark; 3Real-World Evidence and Epidemiology, H. Lundbeck A/S, Valby, Denmark; 4Global Analytics, Lundbeck SAS, Issy-les-Moulineaux, France; 5Health Economics and Outcomes Research, Lundbeck, Deerfield, IL, USA; 6Research and Teaching Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, University of Barcelona, Sant Boi de Llobregat, Barcelona, Spain Background: Major depressive disorder (MDD) is associated with significant impairments in health-related quality of life (HRQoL) and everyday functioning. This cohort study investigated the long-term development of HRQoL in patients with MDD and its association with patient characteristics, including depressive symptom severity and cognitive symptoms.Methods: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study was a longitudinal cohort study conducted in 1,159 outpatients aged 18–65 years with MDD in France, Germany, Spain, Sweden, and the UK. The patients were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. HRQoL was assessed using the Medical Outcomes Study Short-Form 12-item Health Survey (SF-12) up to month 12 and the EuroQol Five Dimensions questionnaire up to month 24 (UK only). Depressive symptom severity was assessed up to month 24 by the patient-reported Patient Health Questionnaire and cognitive symptoms by the Perceived Deficit Questionnaire. Multivariate analyses were performed to identify patient characteristics associated with HRQoL.Results: Mental HRQoL was severely impaired at baseline versus normative data (mean [SD] SF-12 mental component summary [MCS], 26.5 [9.2]); mean (SD) physical component summary (PCS) total score was 45.2 (12.1). SF-12 MCS improved over 12 months of follow-up (38.7 [11.6] at month 12), while SF-12 PCS remained stable (45.3 [11.1]). At each assessment time point, there was a clear pattern of lower SF-12 MCS and PCS total score in patients experiencing greater cognitive problems. The mean EuroQol Five Dimensions questionnaire utility index score generally decreased (i.e., worsened) with increasing severity of cognitive and depressive symptoms at all time points up to 24 months. Multivariate analyses identified both depression severity and cognitive symptoms as strongly and significantly associated with poor HRQoL.Conclusion: These findings highlight the importance of recognizing and managing residual symptoms in patients with MDD, including the cognitive symptoms, to restore long-term psychosocial functioning. Keywords: major depressive disorder, health-related quality of life, depression, cognitive symptoms Saragoussi DChristensen MCHammer-Helmich LRive BTouya MHaro JMDove Medical Pressarticlemajor depressive disorderhealth-related quality of lifedepressioncognitive symptomsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1339-1350 (2018)
institution DOAJ
collection DOAJ
language EN
topic major depressive disorder
health-related quality of life
depression
cognitive symptoms
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle major depressive disorder
health-related quality of life
depression
cognitive symptoms
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Saragoussi D
Christensen MC
Hammer-Helmich L
Rive B
Touya M
Haro JM
Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
description Delphine Saragoussi,1 Michael Cronquist Christensen,2 Lene Hammer-Helmich,3 Benoît Rive,4 Maëlys Touya,5 Josep Maria Haro6 1Real-World Evidence and Epidemiology, Lundbeck SAS, Issy-les-Moulineaux, France; 2Medical Affairs Vortioxetine, H. Lundbeck A/S, Valby, Denmark; 3Real-World Evidence and Epidemiology, H. Lundbeck A/S, Valby, Denmark; 4Global Analytics, Lundbeck SAS, Issy-les-Moulineaux, France; 5Health Economics and Outcomes Research, Lundbeck, Deerfield, IL, USA; 6Research and Teaching Unit, Parc Sanitari Sant Joan de Deu, CIBERSAM, University of Barcelona, Sant Boi de Llobregat, Barcelona, Spain Background: Major depressive disorder (MDD) is associated with significant impairments in health-related quality of life (HRQoL) and everyday functioning. This cohort study investigated the long-term development of HRQoL in patients with MDD and its association with patient characteristics, including depressive symptom severity and cognitive symptoms.Methods: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study was a longitudinal cohort study conducted in 1,159 outpatients aged 18–65 years with MDD in France, Germany, Spain, Sweden, and the UK. The patients were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. HRQoL was assessed using the Medical Outcomes Study Short-Form 12-item Health Survey (SF-12) up to month 12 and the EuroQol Five Dimensions questionnaire up to month 24 (UK only). Depressive symptom severity was assessed up to month 24 by the patient-reported Patient Health Questionnaire and cognitive symptoms by the Perceived Deficit Questionnaire. Multivariate analyses were performed to identify patient characteristics associated with HRQoL.Results: Mental HRQoL was severely impaired at baseline versus normative data (mean [SD] SF-12 mental component summary [MCS], 26.5 [9.2]); mean (SD) physical component summary (PCS) total score was 45.2 (12.1). SF-12 MCS improved over 12 months of follow-up (38.7 [11.6] at month 12), while SF-12 PCS remained stable (45.3 [11.1]). At each assessment time point, there was a clear pattern of lower SF-12 MCS and PCS total score in patients experiencing greater cognitive problems. The mean EuroQol Five Dimensions questionnaire utility index score generally decreased (i.e., worsened) with increasing severity of cognitive and depressive symptoms at all time points up to 24 months. Multivariate analyses identified both depression severity and cognitive symptoms as strongly and significantly associated with poor HRQoL.Conclusion: These findings highlight the importance of recognizing and managing residual symptoms in patients with MDD, including the cognitive symptoms, to restore long-term psychosocial functioning. Keywords: major depressive disorder, health-related quality of life, depression, cognitive symptoms 
format article
author Saragoussi D
Christensen MC
Hammer-Helmich L
Rive B
Touya M
Haro JM
author_facet Saragoussi D
Christensen MC
Hammer-Helmich L
Rive B
Touya M
Haro JM
author_sort Saragoussi D
title Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
title_short Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
title_full Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
title_fullStr Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
title_full_unstemmed Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study
title_sort long-term follow-up on health-related quality of life in major depressive disorder: a 2-year european cohort study
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/b350346aca85438eb85845a04360f92e
work_keys_str_mv AT saragoussid longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
AT christensenmc longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
AT hammerhelmichl longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
AT riveb longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
AT touyam longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
AT harojm longtermfollowuponhealthrelatedqualityoflifeinmajordepressivedisordera2yeareuropeancohortstudy
_version_ 1718403461432737792